Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-23-036125
Filing Date
2023-07-31
Accepted
2023-07-31 21:45:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3132
  Complete submission text file 0000950170-23-036125.txt   4495
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40655 | Film No.: 231129360
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208 SEATTLE WA 98102
Business Address
Simpson Adam K. (Reporting) CIK: 0001873839 (see all company filings)

Type: 144